Digital therapeutics company goes public in SPAC merger

In another example of the growing popularity of the SPAC merger, digital medicine company Akili Interactive is to list on the Nasdaq in this way, with the deal expected to close in mid-2022.

The new company, which will adopt the ticker AKLI, will focus on developing a new class of digital medicines for people living with cognitive impairment.

The deal values the company at an equity value of approximately $1 billion, and is expected to provide up to $412 million in gross cash proceeds.